Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 22, 2021

SELL
$106.9 - $167.73 $224,490 - $352,233
-2,100 Closed
0 $0
Q4 2020

Apr 01, 2021

BUY
$84.4 - $177.39 $177,240 - $372,519
2,100 New
2,100 $291,000
Q3 2020

Nov 02, 2020

SELL
$72.98 - $90.0 $43,788 - $54,000
-600 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$46.91 - $78.22 $28,145 - $46,932
600 New
600 $47,000

Others Institutions Holding RARE

About Ultragenyx Pharmaceutical Inc.


  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $2.95B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.